![]() ![]() This recommendation applies to community-dwelling older adults 65 years or older, without recognized signs or symptoms of cognitive impairment. 7, 8 In this recommendation statement, “cognitive impairment” refers to both dementia and MCI. 4-6 The prevalence of MCI is difficult to estimate, in part because of differing diagnostic criteria, leading to a wide range of prevalence estimates (3%-42%) in adults 65 years or older. 3 However, studies have also shown that between 10% and 40% of persons with MCI may return to normal cognition over approximately 4 to 5 years. One systematic review found that 32% of persons with MCI develop dementia over 5 years. Some persons with MCI may progress to dementia, while some do not. Mild cognitive impairment (MCI) differs from dementia in that the impairment is not severe enough to interfere with independent daily functioning. Dementia affects an estimated 3.2% of persons aged 65 to 74 years, 9.9% of those aged 75 to 84 years, and 29.3% of those 85 years or older. 1 Dementia affects an estimated 2.4 to 5.5 million persons in the United States, and its prevalence increases with age. The 6 cognitive domains identified in the DSM-5 are complex attention, executive function, learning and memory, language, perceptual motor function, and social cognition. This includes more details on the rationale of the recommendation, including benefits and harms supporting evidence and recommendations of others.Īccording to the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) ( DSM-5), dementia (also known as major neurocognitive disorder) is defined by a significant decline in 1 or more cognitive domains that interferes with a person’s independence in daily activities. Visit the USPSTF website ( ) to read the full recommendation statement. Where to read the full recommendation statement? Clinicians should remain alert to early signs or symptoms of cognitive impairment (eg, problems with memory or language) and evaluate as appropriate. There is insufficient evidence to recommend for or against screening for cognitive impairment. This recommendation is consistent with the 2014 USPSTF statement It does not apply to persons who are hospitalized or living in institutions such as nursing homes. More research is needed.Ĭommunity-dwelling adults 65 years and older without recognized signs or symptoms of cognitive impairment. The USPSTF found that the evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment in older adults. For asymptomatic, community-dwelling adults 65 years and older: I statement ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |